A Randomized, Double-Blind, Placebo-Controlled Study of Single Dose Rituximab as Induction in Renal Transplantation
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Transplantation
Reference5 articles.
1. Successful ABO-incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximax.;Tyden;Transplantation,2003
2. . ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximaba three-year follow-up.;Genberg;Transplantation,2008
3. . A randomized, double-blind, placebo-controlled study of single-dose rituximab as induction in renal transplantation.;Tyden;Transplantation,2009
4. . Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients.;Kamar;Am J Transplant,2009
5. . B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.;Kyaw;Circ Res,2001
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unlocking Transplant Tolerance with Biomaterials;Advanced Healthcare Materials;2024-07-03
2. ABO Incompatible Kidney Transplantation Without B-cell Depletion is Associated With Increased Early Acute Rejection: A Single-Center Australian Experience;Transplant International;2023-09-20
3. Additional Benefits of Rituximab and Plasma Exchange on Top of Standard Induction Therapy in Kidney Transplant Recipients With a Negative CDC Crossmatch but High Preformed Donor Specific Antibody Titer;Transplant International;2023-03-28
4. Recommendations for living donor kidney transplantation;Nefrología (English Edition);2022-12
5. Recomendaciones para el trasplante renal de donante vivo;Nefrología;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3